Vimarsana
Biggest News Aggregation in the World

Page 49 - General Internal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General Internal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Internal Today - Breaking & Trending Today

Emory expanding post-COVID clinics for 'long haulers' - Vimarsana News

Emory expanding post-COVID clinics for 'long haulers'

Tags » Emory physicians have established post-COVID clinics to provide follow-up care for people who have recovered from their acute illnesses, yet continue to experience persistent symptoms such as shortness of breath, chronic pain, dizziness and neuromuscular weakness. Researchers plan to investigate the origin of “long haul COVID”, which can take a variety of forms. The co-directors of the Emory Executive Park post-COVID clinic are Alex Truong, MD, MPH and Adviteeya Dixit, MD. Truong and Dixit started their post-COVID clinic in the fall of 2020, after seeing the need among patients wh...

Source: emory.edu
Take-at-home tests boost colorectal cancer screening 10x for the underserved - Vimarsana News

Take-at-home tests boost colorectal cancer screening 10x for the underserved

 E-Mail Colorectal cancer screening rates jumped by more than 1,000 percent when researchers sent take-at-home tests to patients overdue for testing at a community health center that predominantly serves people of color. Instead of the oft-standard text message that simply reminds a patient that they are overdue for screening, researchers from the Perelman School of Medicine at the University of Pennsylvania made it the default to send a take-at-home test to the patient's home unless they opted out via a text message prompt. The research was published in the Journal of General Internal Medi...

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations - Vimarsana News

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers. The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine. This study highlights the blind spot in how clinical trials are done in the United States. Researchers, hospitals and pharmaceut...

Study examines link between health literacy and actionable memory for medication-taking - Vimarsana News

Study examines link between health literacy and actionable memory for medication-taking

Study examines link between health literacy and actionable memory for medication-taking It is important for patients to understand the information they need for making health decisions, yet studies have shown that a large segment of the population lacks the health literacy to do so. Health literacy refers to capacity of people to obtain, process, and understand health information needed for making health decisions. A researcher in the School of Information Sciences at the University of Illinois Urbana-Champaign is addressing this topic. Many people have inadequate health literacy to support t...

Most vulnerable often overlooked in clinical trials of new treatments for COVID-19 - Vimarsana News

Most vulnerable often overlooked in clinical trials of new treatments for COVID-19

 E-Mail Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers. The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine. "This study highlights the blind spot in how clinical trials are done in the United States," said senior author Neda Laiteerapong, MD, MS, a general internist and associate director of the Center for Chronic Di...